Document is current
Any future updates will be listed below
-
Authors
Kang, HyunJun
Hoang, Dinh Hoa
Valerio, Melissa
Pathak, Khyatiben
Zhang, Lianjun
Buettner, Ralf
Chen, Fang https://orcid.org/0000-0002-8871-2752
Estrella, Katrina https://orcid.org/0009-0003-0418-8741
Graff, William
Li, Zhuo
Xie, Jun
Horne, David https://orcid.org/0000-0002-9300-1082
Kuo, Ya-Huei https://orcid.org/0000-0003-2595-0419
Zhang, Bin https://orcid.org/0000-0003-4703-7524
Pirrotte, Patrick
Nguyen, Le Xuan Truong
Marcucci, Guido https://orcid.org/0000-0002-3983-5908
- License Information
-
More Information
Article History
Received: 27 November 2023
Revised: 6 January 2024
Accepted: 8 January 2024
First Online: 17 January 2024
Competing interests
: WG, GM, LXTN and DHH are shareholders of Ostentus Therapeutic Inc. The remaining authors declare that there is no conflict of interest regarding the publication of this article.
: Normal HSCs and AML samples were obtained from healthy donors and patients at the City of Hope National Medical Center (COHNMC), under the City of Hope Institutional Review Board approved banking protocols (#06229, #03162, #07047 or #18067) in accordance with assurances filed with and approved by the Department of Health and Human Services and meeting all requirements of the Declaration of Helsinki. Written informed consent was obtained from donors (#06229) or patients (#03162, #07047 or #18067) prior to specimen acquisition.
